 The FDA has approved a new Alzheimer's treatment from drug maker Eli Lilly. The rundown from CBS's Dr. John LaPook. It slowed cognitive decline overall by about 22% over 18 months. Previous trials over the years that have tried removing amyloid from the brain have not worked. And it's probably working now because more advanced brain scans can pick up the disease earlier so the drug can be given much sooner.